{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:03:43Z","timestamp":1787508223055,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Methyl-CpG binding protein 2 (MeCP2) is a chromatin-associated transcriptional regulator that modulates neuronal gene programs in response to environmental stimuli. Although MeCP2 has been implicated in stress responses and depression, its cell-type-specific functions within defined limbic circuits remain incompletely understood. Here, using a chronic restraint stress (CRS) model, we show that CRS selectively reduces MeCP2 protein in dopamine D2 receptor (D2R)-expressing medium spiny neurons in the nucleus accumbens (NAc). D2R-restricted MeCP2 knockdown was sufficient to increase immobility in the forced swim test, whereas Cre-dependent restoration of MeCP2 in NAc D2R neurons attenuated CRS-associated behavioral alterations across affective coping, anxiety-like behavior and reward sensitivity. Ex vivo multielectrode array recordings combined with optogenetic stimulation revealed that CRS-associated suppression of NAc activity was normalized toward control levels by MeCP2 restoration. To profile molecular correlates, we performed cell-type-resolved GeoMx digital spatial transcriptomics in virally labeled NAc D2R neurons and found that MeCP2 overexpression was associated with attenuation of CRS-linked transcriptional perturbations, prominently involving synaptic and neuronal communication-related programs. In parallel, we detected CRS-responsive molecular signatures in the ventral pallidum that shifted with NAc D2R-restricted MeCP2 restoration, although these downstream profiles are not projection-resolved. Collectively, our findings identify a D2R neuron-biased role for MeCP2 in the NAc and support the view that restoring MeCP2 in this cell population is associated with mitigation of CRS-induced depression-like phenotypes and accompanying circuit\/transcriptomic signatures.<\/jats:p>","DOI":"10.1038\/s12276-026-01721-3","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:43:20Z","timestamp":1778557400000},"page":"1657-1673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MeCP2 regulates cell-type-specific functions of depressive-like symptoms in the nucleus accumbens"],"prefix":"10.1038","volume":"58","author":[{"given":"Jinhee","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun A","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazarii","family":"Frankiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjeong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Mi","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangjoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4763-5009","authenticated-orcid":false,"given":"Heh-In","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"1721_CR1","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224\u20131229 (2008).","journal-title":"Science"},{"key":"1721_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1146\/annurev-cellbio-092910-154121","volume":"27","author":"J Guy","year":"2011","unstructured":"Guy, J., Cheval, H., Selfridge, J. & Bird, A. The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 27, 631\u2013652 (2011).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1721_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/cells11040748","volume":"11","author":"CL S\u00e1nchez-Lafuente","year":"2022","unstructured":"S\u00e1nchez-Lafuente, C. L., Kalynchuk, L. E., Caruncho, H. J. & Ausi\u00f3, J. The role of MeCP2 in regulating synaptic plasticity in the context of stress and depression. Cells 11, 748 (2022).","journal-title":"Cells"},{"key":"1721_CR4","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.3892\/mmr.2015.4104","volume":"12","author":"M Su","year":"2015","unstructured":"Su, M., Hong, J., Zhao, Y., Liu, S. & Xue, X. MeCP2 controls hippocampal brain-derived neurotrophic factor expression via homeostatic interactions with microRNA-132 in rats with depression. Mol. Med. Rep. 12, 5399\u20135406 (2015).","journal-title":"Mol. Med. Rep."},{"key":"1721_CR5","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/nn.2615","volume":"13","author":"H-I Im","year":"2010","unstructured":"Im, H.-I., Hollander, J. A., Bali, P. & Kenny, P. J. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 13, 1120\u20131127 (2010).","journal-title":"Nat. Neurosci."},{"key":"1721_CR6","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1038\/npp.2016.96","volume":"41","author":"CR Lewis","year":"2016","unstructured":"Lewis, C. R. et al. Interactions between early life stress, nucleus accumbens MeCP2 expression, and methamphetamine self-administration in male rats. Neuropsychopharmacology 41, 2851\u20132861 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"1721_CR7","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s00213-022-06176-8","volume":"239","author":"L Huang","year":"2022","unstructured":"Huang, L. et al. The role of MeCP2 and the BDNF\/TrkB signaling pathway in the stress resilience of mice subjected to CSDS. Psychopharmacology 239, 2921\u20132929 (2022).","journal-title":"Psychopharmacology"},{"key":"1721_CR8","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41593-021-00868-8","volume":"24","author":"J-W Kim","year":"2021","unstructured":"Kim, J.-W. et al. Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation. Nat. Neurosci. 24, 1100\u20131109 (2021).","journal-title":"Nat. Neurosci."},{"key":"1721_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.biopsych.2016.09.007","volume":"81","author":"TC Francis","year":"2017","unstructured":"Francis, T. C. & Lobo, M. K. Emerging role for nucleus accumbens medium spiny neuron subtypes in depression. Biol. Psychiatry 81, 645\u2013653 (2017).","journal-title":"Biol. Psychiatry"},{"key":"1721_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.brainresbull.2023.03.004","volume":"196","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y., Zou, M., Wang, Y. & Wang, Y. Nucleus accumbens in the pathogenesis of major depressive disorder: a brief review. Brain Res. Bull. 196, 68\u201375 (2023).","journal-title":"Brain Res. Bull."},{"key":"1721_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrn3381","volume":"14","author":"SJ Russo","year":"2013","unstructured":"Russo, S. J. & Nestler, E. J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 14, 609\u2013625 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"1721_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.biopsych.2014.07.021","volume":"77","author":"TC Francis","year":"2015","unstructured":"Francis, T. C. et al. Nucleus accumbens medium spiny neuron subtypes mediate depression-related outcomes to social defeat stress. Biol. Psychiatry 77, 212\u2013222 (2015).","journal-title":"Biol. Psychiatry"},{"key":"1721_CR13","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1038\/s41380-019-0484-3","volume":"25","author":"C Soares-Cunha","year":"2020","unstructured":"Soares-Cunha, C. et al. Nucleus accumbens medium spiny neurons subtypes signal both reward and aversion. Mol. Psychiatry 25, 3241\u20133255 (2020).","journal-title":"Mol. Psychiatry"},{"key":"1721_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","volume":"59","author":"EJ Nestler","year":"2006","unstructured":"Nestler, E. J. & Carlezon, W. A. Jr The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59, 1151\u20131159 (2006).","journal-title":"Biol. Psychiatry"},{"key":"1721_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biopsych.2009.09.013","volume":"67","author":"BH Bewernick","year":"2010","unstructured":"Bewernick, B. H. et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol. Psychiatry 67, 110\u2013116 (2010).","journal-title":"Biol. Psychiatry"},{"key":"1721_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","volume":"52","author":"Z Zhou","year":"2006","unstructured":"Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255\u2013269 (2006).","journal-title":"Neuron"},{"key":"1721_CR17","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.jneumeth.2021.109452","volume":"368","author":"S-C Kim","year":"2022","unstructured":"Kim, S.-C., Kim, A., Park, J.-Y. & Hwang, E. M. Improved AAV vector system for cell-type-specific RNA interference. J. Neurosci. Methods 368, 109452 (2022).","journal-title":"J. Neurosci. Methods"},{"key":"1721_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature11160","volume":"487","author":"BK Lim","year":"2012","unstructured":"Lim, B. K., Huang, K. W., Grueter, B. A., Rothwell, P. E. & Malenka, R. C. Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature 487, 183\u2013189 (2012).","journal-title":"Nature"},{"key":"1721_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01312-y","volume":"11","author":"X-Q Wang","year":"2021","unstructured":"Wang, X.-Q. et al. PTEN in prefrontal cortex is essential in regulating depression-like behaviors in mice. Transl. Psychiatry 11, 185 (2021).","journal-title":"Transl. Psychiatry"},{"key":"1721_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brainresbull.2020.05.013","volume":"162","author":"J Li","year":"2020","unstructured":"Li, J., Sha, L. & Xu, Q. An early increase in glutamate is critical for the development of depression-like behavior in a chronic restraint stress (CRS) model. Brain Res. Bull. 162, 59\u201366 (2020).","journal-title":"Brain Res. Bull."},{"key":"1721_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.pnpbp.2012.12.012","volume":"43","author":"W Marsden","year":"2013","unstructured":"Marsden, W. Synaptic plasticity in depression: molecular, cellular and functional correlates. Prog. Neuropsychopharmacol. Biol. Psychiatry 43, 168\u2013184 (2013).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1721_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","volume":"28","author":"GR Fries","year":"2023","unstructured":"Fries, G. R., Saldana, V. A., Finnstein, J. & Rein, T. Molecular pathways of major depressive disorder converge on the synapse. Mol. Psychiatry 28, 284\u2013297 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1721_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13451","volume":"20","author":"JL Huang","year":"2021","unstructured":"Huang, J. L. et al. MeCP2 prevents age-associated cognitive decline via restoring synaptic plasticity in a senescence-accelerated mouse model. Aging Cell 20, e13451 (2021).","journal-title":"Aging Cell"},{"key":"1721_CR24","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.1038\/s41380-021-01217-8","volume":"26","author":"H-D Kim","year":"2021","unstructured":"Kim, H.-D. et al. Shisa6 mediates cell-type specific regulation of depression in the nucleus accumbens. Mol. Psychiatry 26, 7316\u20137327 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1721_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fncel.2018.00159","volume":"12","author":"H Ho","year":"2018","unstructured":"Ho, H. et al. A guide to single-cell transcriptomics in adult rodent brain: the medium spiny neuron transcriptome revisited. Front. Cell. Neurosci. 12, 159 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"1721_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","volume":"34","author":"CR Gerfen","year":"2011","unstructured":"Gerfen, C. R. & Surmeier, D. J. Modulation of striatal projection systems by dopamine. Annu. Rev. Neurosci. 34, 441\u2013466 (2011).","journal-title":"Annu. Rev. Neurosci."},{"key":"1721_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"J-M Beaulieu","year":"2011","unstructured":"Beaulieu, J.-M. & Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182\u2013217 (2011).","journal-title":"Pharmacol. Rev."},{"key":"1721_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nn1654","volume":"9","author":"MK Lobo","year":"2006","unstructured":"Lobo, M. K., Karsten, S. L., Gray, M., Geschwind, D. H. & Yang, X. W. FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nat. Neurosci. 9, 443\u2013452 (2006).","journal-title":"Nat. Neurosci."},{"key":"1721_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0304-3940(91)90391-6","volume":"130","author":"SN Schiffmann","year":"1991","unstructured":"Schiffmann, S. N., Libert, F., Vassart, G. & Vanderhaeghen, J.-J. Distribution of adenosine A2 receptor mRNA in the human brain. Neurosci. Lett. 130, 177\u2013181 (1991).","journal-title":"Neurosci. Lett."},{"key":"1721_CR30","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.neuron.2023.02.013","volume":"111","author":"A Godino","year":"2023","unstructured":"Godino, A. et al. Transcriptional control of nucleus accumbens neuronal excitability by retinoid X receptor alpha tunes sensitivity to drug rewards. Neuron 111, 1453\u20131467 (2023).","journal-title":"Neuron"},{"key":"1721_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv5986","volume":"11","author":"L He","year":"2025","unstructured":"He, L. et al. Microglial BDNF modulates arketamine\u2019s antidepressant-like effects through cortico-accumbal pathways. Sci. Adv. 11, eadv5986 (2025).","journal-title":"Sci. Adv."},{"key":"1721_CR32","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.biopsych.2019.05.020","volume":"86","author":"JW Koo","year":"2019","unstructured":"Koo, J. W., Chaudhury, D., Han, M.-H. & Nestler, E. J. Role of mesolimbic brain-derived neurotrophic factor in depression. Biol. Psychiatry 86, 738\u2013748 (2019).","journal-title":"Biol. Psychiatry"},{"key":"1721_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.cell.2017.06.015","volume":"170","author":"D Knowland","year":"2017","unstructured":"Knowland, D. et al. Distinct ventral pallidal neural populations mediate separate symptoms of depression. Cell 170, 284\u2013297 (2017).","journal-title":"Cell"},{"key":"1721_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1523\/JNEUROSCI.0971-22.2022","volume":"43","author":"G Morais-Silva","year":"2023","unstructured":"Morais-Silva, G. et al. Molecular, circuit, and stress response characterization of ventral pallidum Npas1-neurons. J. Neurosci. 43, 405\u2013418 (2023).","journal-title":"J. Neurosci."},{"key":"1721_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq6017","volume":"10","author":"L Yang","year":"2024","unstructured":"Yang, L. et al. Transcriptomic landscape of mammalian ventral pallidum at single-cell resolution. Sci. Adv. 10, eadq6017 (2024).","journal-title":"Sci. Adv."},{"key":"1721_CR36","doi-asserted-by":"publisher","first-page":"eadp3059","DOI":"10.1126\/sciadv.adp3059","volume":"11","author":"DJ Ottenheimer","year":"2025","unstructured":"Ottenheimer, D. J. et al. Single-cell sequencing of rodent ventral pallidum reveals diverse neuronal subtypes with noncanonical interregional continuity. Sci. Adv. 11, eadp3059 (2025).","journal-title":"Sci. Adv."},{"key":"1721_CR37","doi-asserted-by":"publisher","first-page":"e70182","DOI":"10.1111\/jcmm.70182","volume":"28","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Zheng, Y. & Liu, S. KRAS mutation promotes the colonization of Fusobacterium nucleatum in colorectal cancer by down-regulating SERTAD4. J. Cell. Mol. Med. 28, e70182 (2024).","journal-title":"J. Cell. Mol. Med."},{"key":"1721_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/npp.2012.116","volume":"38","author":"ES Na","year":"2013","unstructured":"Na, E. S., Nelson, E. D., Kavalali, E. T. & Monteggia, L. M. The impact of MeCP2 loss-or gain-of-function on synaptic plasticity. Neuropsychopharmacology 38, 212\u2013219 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1721_CR39","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cub.2006.02.062","volume":"16","author":"ED Nelson","year":"2006","unstructured":"Nelson, E. D., Kavalali, E. T. & Monteggia, L. M. MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr. Biol. 16, 710\u2013716 (2006).","journal-title":"Curr. Biol."},{"key":"1721_CR40","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1523\/JNEUROSCI.2674-14.2014","volume":"34","author":"K Sugino","year":"2014","unstructured":"Sugino, K. et al. Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes. J. Neurosci. 34, 12877\u201312883 (2014).","journal-title":"J. Neurosci."},{"key":"1721_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuron.2007.08.018","volume":"56","author":"H-T Chao","year":"2007","unstructured":"Chao, H.-T., Zoghbi, H. Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58\u201365 (2007).","journal-title":"Neuron"},{"key":"1721_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.nbd.2010.01.018","volume":"38","author":"L Wood","year":"2010","unstructured":"Wood, L. & Shepherd, G. M. Synaptic circuit abnormalities of motor-frontal layer 2\/3 pyramidal neurons in a mutant mouse model of Rett syndrome. Neurobiol. Dis. 38, 281\u2013287 (2010).","journal-title":"Neurobiol. Dis."},{"key":"1721_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/hipo.22360","volume":"25","author":"G Calfa","year":"2015","unstructured":"Calfa, G., Li, W., Rutherford, J. M. & Pozzo-Miller, L. Excitation\/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice. Hippocampus 25, 159\u2013168 (2015).","journal-title":"Hippocampus"},{"key":"1721_CR44","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1523\/JNEUROSCI.5503-09.2010","volume":"30","author":"DD Kline","year":"2010","unstructured":"Kline, D. D., Ogier, M., Kunze, D. L. & Katz, D. M. Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J. Neurosci. 30, 5303\u20135310 (2010).","journal-title":"J. Neurosci."},{"key":"1721_CR45","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1152\/jn.00601.2009","volume":"103","author":"Z-W Zhang","year":"2010","unstructured":"Zhang, Z.-W., Zak, J. D. & Liu, H. MeCP2 is required for normal development of GABAergic circuits in the thalamus. J. Neurophysiol. 103, 2470\u20132481 (2010).","journal-title":"J. Neurophysiol."},{"key":"1721_CR46","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.7150\/thno.68439","volume":"12","author":"S Lee","year":"2022","unstructured":"Lee, S. et al. Dysfunction of striatal MeCP2 is associated with cognitive decline in a mouse model of Alzheimer\u2019s disease. Theranostics 12, 1404 (2022).","journal-title":"Theranostics"},{"key":"1721_CR47","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2165\/11633130-000000000-00000","volume":"72","author":"DC Mathews","year":"2012","unstructured":"Mathews, D. C., Henter, I. D. & Zarate, C. A. Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date. Drugs 72, 1313\u20131333 (2012).","journal-title":"Drugs"},{"key":"1721_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1517\/14728222.9.1.153","volume":"9","author":"SF Kendell","year":"2005","unstructured":"Kendell, S. F., Krystal, J. H. & Sanacora, G. GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin. Ther. Targets 9, 153\u2013168 (2005).","journal-title":"Expert Opin. Ther. Targets"},{"key":"1721_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13578-024-01319-0","volume":"14","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Potassium channels in depression: emerging roles and potential targets. Cell Biosci. 14, 136 (2024).","journal-title":"Cell Biosci."},{"key":"1721_CR50","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41380-018-0283-2","volume":"25","author":"A Tan","year":"2020","unstructured":"Tan, A. et al. Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder. Mol. Psychiatry 25, 1323\u20131333 (2020).","journal-title":"Mol. Psychiatry"},{"key":"1721_CR51","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/cells12030387","volume":"12","author":"Buszka","year":"2023","unstructured":"Buszka, Pyty\u015b, A., Colvin, A., W\u0142odarczyk, D. & J.&W\u00f3jtowicz, T. S-palmitoylation of synaptic proteins in neuronal plasticity in normal and pathological brains. Cells 12, 387 (2023).","journal-title":"Cells"},{"key":"1721_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.conb.2017.02.016","volume":"45","author":"AK Globa","year":"2017","unstructured":"Globa, A. K. & Bamji, S. X. Protein palmitoylation in the development and plasticity of neuronal connections. Curr. Opin. Neurobiol. 45, 210\u2013220 (2017).","journal-title":"Curr. Opin. Neurobiol."},{"key":"1721_CR53","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12035-022-03095-9","volume":"60","author":"W Alhassen","year":"2023","unstructured":"Alhassen, W., Alhassen, S., Chen, J., Monfared, R. V. & Alachkar, A. Cilia in the striatum mediate timing-dependent functions. Mol. Neurobiol. 60, 545\u2013565 (2023).","journal-title":"Mol. Neurobiol."},{"key":"1721_CR54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fncel.2019.00226","volume":"13","author":"M Lucarelli","year":"2019","unstructured":"Lucarelli, M. et al. Anomalies in dopamine transporter expression and primary cilium distribution in the dorsal striatum of a mouse model of Niemann-Pick C1 disease. Front. Cell. Neurosci. 13, 226 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"1721_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/cells11040603","volume":"11","author":"JE Gentile","year":"2022","unstructured":"Gentile, J. E., Carrizales, M. G. & Koleske, A. J. Control of synapse structure and function by actin and its regulators. Cells 11, 603 (2022).","journal-title":"Cells"},{"key":"1721_CR56","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar, C. A. et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856\u2013860 (1997).","journal-title":"Nature"},{"key":"1721_CR57","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1523\/JNEUROSCI.17-07-02295.1997","volume":"17","author":"C JM","year":"1997","unstructured":"JM, C. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17, 2295\u20132313 (1997).","journal-title":"J. Neurosci."},{"key":"1721_CR58","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet, Z. C., Gorski, J. A. & Jones, K. R. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J. Neurosci. 24, 4250\u20134258 (2004).","journal-title":"J. Neurosci."},{"key":"1721_CR59","doi-asserted-by":"publisher","first-page":"1182499","DOI":"10.3389\/fnmol.2023.1182499","volume":"16","author":"E Esvald","year":"2023","unstructured":"Esvald, E., Tuvikene, J. & Kiir, C. Revisiting the expression of BDNF and its receptors in mammalian development. Front. Mol. Neurosci. 16, 1182499 (2023).","journal-title":"Front. Mol. Neurosci."},{"key":"1721_CR60","doi-asserted-by":"publisher","first-page":"1086053","DOI":"10.3389\/fncir.2023.1086053","volume":"17","author":"C Soares-Cunha","year":"2023","unstructured":"Soares-Cunha, C. & Heinsbroek, J. A. Ventral pallidal regulation of motivated behaviors and reinforcement. Front. Neural Circuits 17, 1086053 (2023).","journal-title":"Front. Neural Circuits"},{"key":"1721_CR61","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuroscience.2020.06.013","volume":"441","author":"E Antontseva","year":"2020","unstructured":"Antontseva, E., Bondar, N., Reshetnikov, V. & Merkulova, T. The effects of chronic stress on brain myelination in humans and in various rodent models. Neuroscience 441, 226\u2013238 (2020).","journal-title":"Neuroscience"},{"key":"1721_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8062","volume":"6","author":"RC Bagot","year":"2015","unstructured":"Bagot, R. C. et al. Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nat. Commun. 6, 7062 (2015).","journal-title":"Nat. Commun."},{"key":"1721_CR63","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41380-024-02684-5","volume":"30","author":"Z Cheng","year":"2025","unstructured":"Cheng, Z. et al. Rasd2 regulates depression-like behaviors via DRD2 neurons in the prelimbic cortex afferent to nucleus accumbens core circuit. Mol. Psychiatry 30, 435\u2013449 (2025).","journal-title":"Mol. Psychiatry"},{"key":"1721_CR64","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1567202617666200319141755","volume":"17","author":"W Yang","year":"2020","unstructured":"Yang, W. et al. Knockdown of miR-124 reduces depression-like behavior by targeting CREB1 and BDNF. Curr. Neurovasc. Res. 17, 196\u2013203 (2020).","journal-title":"Curr. Neurovasc. Res."},{"key":"1721_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2021.100311","volume":"14","author":"L Tong","year":"2021","unstructured":"Tong, L. et al. miR-132 downregulation alleviates behavioral impairment of rats exposed to single prolonged stress, reduces the level of apoptosis in PFC, and upregulates the expression of MeCP2 and BDNF. Neurobiol. Stress 14, 100311 (2021).","journal-title":"Neurobiol. Stress"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01721-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01721-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01721-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:50:01Z","timestamp":1780548601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01721-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":65,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1721"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01721-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.07.24.666523","asserted-by":"object"}]},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following patent applications related to the findings of this study, all filed by KIST: \u2022 patent no. 10-2932728 (Republic of Korea) and application no. 18\/598,746 (USA), covering the use of MECP2 as a biomarker for depression diagnosis and as a therapeutic target. \u2022 application nos. 10-2025-0003282 (Republic of Korea) and 19\/322,108 (USA), covering the development of a Cre-dependent viral system for gene regulation of MeCP2; a corresponding PCT\/KR2025\/012274 application has also been filed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}